Search For "drug regulator"
Top drug regulator CDSCO suspends import license of Mumbai-based firm for
Updated : 5 years, 10 months ago IST
New Delhi [India], July 24 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has suspended the import license of Mumbai-based company--Transasia Bio-Medicals which is providing COVID-19 IgG ELISA kit.
Read More
COVID19: Top drug regulator directs states drug controller to be vigilant
Updated : 5 years, 10 months ago IST
New Delhi [India], July 7 (ANI): The country's top drug regulator has directed all drug controller in the States and Union Territories to keep strict vigil to prevent the black marketing and sale of the anti-drug Remdesivir injection above the minimum retail price (MRP).
Read More
Domestic pharma giants-- Cipla, Hetero got DCGI's nod to manufacture, sell
Updated : 5 years, 11 months ago IST
New Delhi [India], June 21 (ANI): In a significant development, India's top drug regulator has given nod to two domestic pharmaceutical companies--Cipla and Hetero for marketing authorization of anti-viral drug Remdesivir only for "restricted emergency use" on COVID-19 patients with moderate
Read More
Anti-viral drug favipiravir gets DGCI nod for 'restricted emergency use' i
Updated : 5 years, 11 months ago IST
New Delhi [India], June 19 (ANI): The Drug Controller General of India (DCGI) has granted permission to anti-viral drug favipiravir for "restricted emergency use" in mild to moderate cases of COVID-19, a senior government official confirmed to ANI.
Read More
Six Indian companies applied to CDSCO for permission to manufacture, marke
Updated : 5 years, 11 months ago IST
New Delhi [India], June 14 (ANI): The Centre on Sunday said that six Indian companies -- Hetero, Cipla, BDR, Jubilant, Mylan and Dr Reddy's Labs -- have applied to Indian Drug Regulatory Agency, Central Drug Standard Control Organisation (CDSCO) for permission to manufacture and market the R
Read More
COVID-19: Pharma giants seek DCGI's approval to manufacture, sell Remdesiv
Updated : 5 years, 11 months ago IST
New Delhi [India], June 4 (ANI): Two domestic pharmaceutical firms--Mylan and Jubilant Life Sciences have approached the country's top drug regulator--Drug Controller General of India (DCGI) to seek its approval to manufacture and sell anti-viral drug 'Remdesivir' in India to combat COVID-19
Read More
Zydus Cadila approaches DCGI to use hepatitis drug for COVID-19 clinical t
Updated : 6 years ago IST
New Delhi [India], May 5 (ANI): The country's top drug regulator, Drug Controller General of India (DCGI), has received an application from Zydus Cadila, the leading global pharmaceutical company in India, to conduct clinical trial using antiviral drug 'Pegylated Interferon Alpha-2b' in adul
Read More
Top drug regulator to ensure no shortage of essential, critical drugs amid
Updated : 6 years, 1 month ago IST
New Delhi [India], April 18 (ANI): Warning against stockpiling of medicines and creating supply chain shortages, the Union health ministry has directed the country's top drug regulator to ensure there is no shortage of essential and critical drugs pertaining to COVID-19 disease and to ensure
Read More
Drug regulator asks states to give clearance to industrial oxygen manufact
Updated : 6 years, 1 month ago IST
New Delhi [India], April 7 (ANI): In a step to ensure adequate supply of `oxygen for medical use' for treating coronavirus patients, the country's top drug regulator has asked drug regulators in all states and UTs to give requisite approvals within 24 hours to the manufacturers of industrial
Read More
Lockdown effect: Top drug regulator instructs release of blocked consignme
Updated : 6 years, 1 month ago IST
New Delhi [India], April 3 (ANI): In the wake of coronavirus lockdown, the Central Drugs Controller has instructed all port offices of Central Drugs Standard Control Organization (CDCSO) to release the consignments of vaccines and critical in vitro diagnostics (IVDs) in public interest.
Read More
European drug regulator approves Biocon's Malaysia insulin facility
Updated : 6 years, 9 months ago IST
Bengaluru (Karnataka) [India], Aug 22 (ANI): Biopharmaceutical major Biocon said on Thursday said its insulin facility in Malaysia has been approved by the European Medicines Agency.
Read More
Action will be taken after Johnson & Johnson baby powder's sample test: Dr
Updated : 7 years, 5 months ago IST
Baddi (Himachal Pradesh) [India], Dec 19 (ANI): Days after India's central drug regulator CDSCO seized samples of Johnson & Johnson baby powder from the firm's plant in Himachal Pradesh's Baddi, state drug controller Navneet Marwaha said that appropriate action will be taken in the ma
Read More